W&T Offshore (WTI) Holder Ajo LP Boosted Stake by $1.61 Million; Gilead Sciences (GILD) Share Value Rose While Cognios Capital Has Trimmed by $1.10 Million Its Holding

May 19, 2018 - By Marie Mckinney

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Ajo Lp increased its stake in W&T Offshore (WTI) by 71.12% based on its latest 2017Q4 regulatory filing with the SEC. Ajo Lp bought 536,021 shares as the company’s stock rose 39.80% while stock markets declined. The institutional investor held 1.29 million shares of the energy company at the end of 2017Q4, valued at $4.27 million, up from 753,682 at the end of the previous reported quarter. Ajo Lp who had been investing in W&T Offshore for a number of months, seems to be bullish on the $1.14B market cap company. The stock decreased 0.60% or $0.05 during the last trading session, reaching $8.22. About 2.96M shares traded or 11.72% up from the average. W&T Offshore, Inc. (NYSE:WTI) has risen 50.71% since May 19, 2017 and is uptrending. It has outperformed by 39.16% the S&P500.

Cognios Capital Llc decreased its stake in Gilead Sciences Inc (GILD) by 37.12% based on its latest 2017Q4 regulatory filing with the SEC. Cognios Capital Llc sold 15,465 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 26,195 shares of the health care company at the end of 2017Q4, valued at $1.88M, down from 41,660 at the end of the previous reported quarter. Cognios Capital Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be less bullish one the $88.44B market cap company. The stock increased 0.62% or $0.42 during the last trading session, reaching $68.02. About 5.42 million shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since May 19, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Ajo Lp, which manages about $24.49 billion and $23.21B US Long portfolio, decreased its stake in Marcus & Millichap (NYSE:MMI) by 74,786 shares to 142,289 shares, valued at $4.64M in 2017Q4, according to the filing. It also reduced its holding in Kohl’s Corp (NYSE:KSS) by 8,242 shares in the quarter, leaving it with 5,850 shares, and cut its stake in Nu Skin Enterprises (NYSE:NUS).

Among 4 analysts covering W&T Offshore (NYSE:WTI), 0 have Buy rating, 2 Sell and 2 Hold. Therefore 0 are positive. W&T Offshore had 14 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of W&T Offshore, Inc. (NYSE:WTI) has “Underweight” rating given on Wednesday, January 10 by Capital One. The stock has “Underweight” rating by Capital One on Tuesday, January 19. The stock of W&T Offshore, Inc. (NYSE:WTI) has “Hold” rating given on Thursday, March 10 by KLR Group. The rating was upgraded by Capital One to “Equal-Weight” on Monday, March 12. The stock of W&T Offshore, Inc. (NYSE:WTI) has “Neutral” rating given on Thursday, August 6 by Global Hunter Securities. As per Monday, October 17, the company rating was downgraded by Barclays Capital. The firm earned “Sector Perform” rating on Monday, August 17 by Iberia Capital Partners. KLR Group downgraded W&T Offshore, Inc. (NYSE:WTI) on Tuesday, May 15 to “Sell” rating.

Since December 18, 2017, it had 0 insider purchases, and 2 selling transactions for $133,631 activity. 29,000 shares valued at $80,910 were sold by GIBBONS JOHN D on Monday, December 18.

More news for W&T Offshore, Inc. (NYSE:WTI) were recently published by: Seekingalpha.com, which released: “W&T Offshore: What An Impressive Recovery” on May 11, 2018. Profitconfidential.com‘s article titled: “Why WTI Stock Is Geared Toward Higher Stock Prices” and published on April 20, 2018 is yet another important article.

Investors sentiment decreased to 1.63 in Q4 2017. Its down 0.31, from 1.94 in 2017Q3. It worsened, as 11 investors sold WTI shares while 32 reduced holdings. 35 funds opened positions while 35 raised stakes. 63.07 million shares or 0.69% less from 63.51 million shares in 2017Q3 were reported. Ajo Ltd Partnership stated it has 0.02% in W&T Offshore, Inc. (NYSE:WTI). Voya Inv Llc reported 42,063 shares stake. Parametric Portfolio Associates Ltd Limited Liability Company, a Washington-based fund reported 586,871 shares. Jpmorgan Chase & Company reported 0% stake. Federated Investors Inc Pa has 168,529 shares for 0% of their portfolio. 21,586 are held by Sg Americas Securities Ltd Liability Corporation. Smith Asset Mgmt LP holds 77,510 shares. Bridgeway Capital Mngmt owns 750,836 shares. Acadian Asset Limited Co holds 0.01% or 668,664 shares in its portfolio. State Board Of Administration Of Florida Retirement System reported 0% stake. Moreover, Meeder Asset Mngmt Inc has 0% invested in W&T Offshore, Inc. (NYSE:WTI) for 9,070 shares. Tudor Investment Et Al accumulated 28,570 shares or 0% of the stock. Qcm Cayman Limited invested in 0.16% or 11,410 shares. Cornerstone Capital invested 0% of its portfolio in W&T Offshore, Inc. (NYSE:WTI). Virtu Financial Ltd holds 60,611 shares or 0.01% of its portfolio.

Investors sentiment decreased to 0.8 in 2017 Q4. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Coastline reported 0.12% in Gilead Sciences, Inc. (NASDAQ:GILD). First Retail Bank Of Omaha accumulated 3,591 shares. Valueworks Lc holds 3.71% or 69,581 shares. Nuveen Asset Ltd Liability, Illinois-based fund reported 976,403 shares. Arrowstreet Limited Partnership holds 0.53% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 3.07 million shares. Sii Investments Wi holds 0.13% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 17,406 shares. Ftb Advisors owns 0.51% invested in Gilead Sciences, Inc. (NASDAQ:GILD) for 72,769 shares. Texas Capital Retail Bank Inc Tx has invested 0.49% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Omers Administration invested in 66,000 shares. Flossbach Von Storch Ag owns 3,770 shares or 0% of their US portfolio. Kansas-based Waddell Reed has invested 0.2% in Gilead Sciences, Inc. (NASDAQ:GILD). Cincinnati Specialty Underwriters Insur Company owns 42,000 shares. 3,777 are owned by Columbia L L C Investment Mngmt. Healthinvest Prns, a Sweden-based fund reported 36,100 shares. 8,376 are owned by Terril Brothers Inc.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Seekingalpha.com which released: “Gilead: What A Disaster” on May 08, 2018, also Seekingalpha.com with their article: “Gilead: Where’s The Next Catalyst?” published on May 18, 2018, Bizjournals.com published: “2 big Bay Area companies look to map, tackle inflammatory diseases” on April 30, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Seekingalpha.com and their article: “Gilead Sciences: Resist Sentiment, Stop Speculating And Invest” published on May 15, 2018 as well as 247Wallst.com‘s news article titled: “Analysts Show More Caution Toward Gilead’s Mystical Recovery” with publication date: May 02, 2018.

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 130 analyst reports since July 29, 2015 according to SRatingsIntel. Wells Fargo upgraded the stock to “Outperform” rating in Tuesday, January 16 report. Maxim Group upgraded it to “Buy” rating and $94.0 target in Thursday, November 30 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Maxim Group on Friday, April 29. UBS maintained the stock with “Buy” rating in Friday, April 29 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Wednesday, October 4 by Jefferies. Gabelli initiated the shares of GILD in report on Wednesday, June 1 with “Buy” rating. The firm has “Buy” rating by Jefferies given on Tuesday, September 6. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Hold” rating given on Tuesday, October 3 by Needham. Barclays Capital maintained it with “Overweight” rating and $90 target in Wednesday, May 2 report. The stock has “Buy” rating by Jefferies on Friday, January 26.

Analysts await Gilead Sciences, Inc. (NASDAQ:GILD) to report earnings on July, 25. They expect $1.43 EPS, down 43.03% or $1.08 from last year’s $2.51 per share. GILD’s profit will be $1.86B for 11.89 P/E if the $1.43 EPS becomes a reality. After $1.37 actual EPS reported by Gilead Sciences, Inc. for the previous quarter, Wall Street now forecasts 4.38% EPS growth.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>